Alignment Healthcare, Inc. - Common Stock (ALHC)
12.41
-0.74 (-5.63%)
NASDAQ · Last Trade: Jul 20th, 3:20 AM EDT
Detailed Quote
Previous Close | 13.15 |
---|---|
Open | 13.26 |
Bid | 12.25 |
Ask | 12.42 |
Day's Range | 12.38 - 13.26 |
52 Week Range | 7.920 - 21.06 |
Volume | 1,852,051 |
Market Cap | 2.34B |
PE Ratio (TTM) | -25.85 |
EPS (TTM) | -0.5 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 3,225,988 |
Chart
About Alignment Healthcare, Inc. - Common Stock (ALHC)
Alignment Healthcare Inc is a leading healthcare company that focuses on providing innovative and personalized health care solutions, primarily for seniors. The company utilizes a technology-driven approach to deliver high-quality, value-based care, ensuring that patients receive tailored support and resources to manage their health effectively. By leveraging data analytics and a network of healthcare professionals, Alignment aims to improve health outcomes while enhancing patient experiences and reducing healthcare costs. The company emphasizes preventive care and proactive health management, positioning itself as a pivotal player in the evolving landscape of healthcare services for aging populations. Read More
News & Press Releases
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT.
By Alignment Healthcare USA, LLC · Via GlobeNewswire · July 10, 2025
Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC)
jumped 3.2% in the afternoon session after the company announced a significant legal victory against the Centers for Medicare & Medicaid Services (CMS), which boosted its Arizona HMO plan's 2025 star rating. The federal court ruling, announced today, increases the plan's rating from 3.5 to 4 stars. This is a crucial development for the Medicare Advantage provider, as plans rated 4 stars or higher qualify for bonus payments from CMS. As a result of the decision, 100% of Alignment's members are now enrolled in plans with a 4-star rating or higher. The company stated it will reinvest the bonus payments to enhance member benefits and services. This legal win not only has positive financial implications but also validates the quality of care the company provides, potentially attracting more members and increasing its market share in the competitive Medicare Advantage space.
Via StockStory · July 8, 2025
Court ruling means 100% of Alignment’s members now enrolled in plans rated 4 stars or greater
By Alignment Healthcare USA, LLC · Via GlobeNewswire · July 8, 2025
Over the past six months, Alignment Healthcare has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $13.61, representing a healthy 16.3% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · July 3, 2025
Unprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Via StockStory · June 23, 2025
ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025.
By Alignment Healthcare USA, LLC · Via GlobeNewswire · June 10, 2025

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Alignment Healthcare (NASDAQ:ALHC) and its peers.
Via StockStory · June 5, 2025

ORANGE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been named to the 2025 Fortune 1000 list, marking its debut among the top U.S. public companies ranked by total revenue. The recognition reflects Alignment’s rapid growth and financial momentum, driven by its innovative, senior-focused model of care.
By Alignment Healthcare USA, LLC · Via GlobeNewswire · June 3, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Via StockStory · May 27, 2025
ORANGE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, at 2 p.m. CDT.
By Alignment Healthcare USA, LLC · Via GlobeNewswire · May 21, 2025
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Via StockStory · May 20, 2025
Pharmacy Quality Alliance award reaffirms Alignment’s commitment to medication adherence and pharmacy excellence for seniors
By Alignment Healthcare USA, LLC · Via GlobeNewswire · May 19, 2025
Health insurance company Alignment Healthcare (NASDAQ:ALHC) announced better-than-expected revenue in Q1 CY2025, with sales up 47.5% year on year to $926.9 million. The company expects next quarter’s revenue to be around $957.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 15, 2025
Health insurance company Alignment Healthcare (NASDAQ:ALHC) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 47.5% year on year to $926.9 million. Guidance for next quarter’s revenue was better than expected at $957.5 million at the midpoint, 1.3% above analysts’ estimates. Its GAAP loss of $0.05 per share was 59.7% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its first quarter ended March 31, 2025.
By Alignment Healthcare USA, LLC · Via GlobeNewswire · May 1, 2025
Health insurance company Alignment Healthcare (NASDAQ:ALHC)
will be reporting earnings tomorrow after market hours. Here’s what you need to know.
Via StockStory · April 30, 2025
ORANGE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the BofA Securities Healthcare Conference on Wednesday, May 14, at 2:20 p.m. PDT.
By Alignment Healthcare USA, LLC · Via GlobeNewswire · April 28, 2025
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · April 24, 2025
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Via StockStory · April 22, 2025
Via Benzinga · April 15, 2025
Strategic moves integrate care, service and technology to advance responsible AI and seamless member experience
By Alignment Healthcare USA, LLC · Via GlobeNewswire · April 15, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand.
The result? Over the past six months, the industry has tumbled by 14.1%. This performance was worse than the S&P 500’s 9.3% decline.
Via StockStory · April 11, 2025